Table 1. Clinicopathological information of studied cases.
| Sample | Age | Sex | Site | Size (cm) | Chemotherapy | Survival (months) | Recurrence | Outcome | Analysis |
|---|---|---|---|---|---|---|---|---|---|
| ACC-1 | 78 | M | BT | 4 | GEM, S-1 | 16 | Liver | DOD | WE, IHC |
| ACC-2 | 67 | M | B | 5.5 | CDDP | 59 | Liver (CR) | Alive | WE, IHC |
| ACC-3 | 78 | F | T | 8.5 | None | 21 | None | Alive | WE, IHC |
| ACC-4 | 68 | M | BT | 12.3 | None | 15.7 | Liver | DOD | TS, IHC |
| ACC-5 | 59 | M | B | 4.7 | LAK, DV, S-1 | 23 | Liver, Peritoneum | DOD | TS, IHC |
| ACC-6 | 56 | F | H | 5 | None | 101 | None | Alive | TS, IHC |
| ACC-7 | 71 | M | H | 2 | GEM, S-1, CPT-11 | 12 | Liver | DOD | TS, IHC |
| ACC-8 | 53 | M | T | 4.3 | GEM | 23 | Liver | DOD | IHC |
| ACC-9 | 58 | M | BT | 18 | None | 94 | None | Alive | IHC |
| ACC-10 | 55 | M | H | 7 | None | 159 | None | Alive | IHC |
| ACC-11 | 70 | M | BT | 10 | S-1 | 6 | Liver | DOD | IHC |
Abbreviations are B, pancreatic body; BT, pancreatic body and tail; CDDP, cisplatinum; CR, complete remission; DOD, dead on disease; DV, dentritic cell vaccination; F, female; GEM, gemcitabin; H, pancreatic head; IHC, immunohistochemistry; LAK, lymphokine-activated killer cell; M, male; T, pancreatic tai; TS, target sequencing; and WE, whole-exome sequencing.